1,2-Cyclopentanedione, 3-ethyl-
Common Name: |
1,2-Cyclopentanedione, 3-ethyl- |
IUPAC Name: |
3-ethylcyclopentane-1,2-dione |
Molecular Formula: |
C7H10O2 |
SMILES: |
CCC1CCC(=O)C1=O |
Inchi: |
nChI=1S/C7H10O2/c1-2-5-3-4-6(8)7(5)9/h5H,2-4H2,1H3 |
Inchi Key: |
RRVYBPVLSILURP-UHFFFAOYSA-N |
Cas No: |
13494-08-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
126.15 |
Mass (g/mol) |
126.068 |
Molar Refractivity |
34.05 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
1 |
Rings |
1 |
TPSA |
34.14 |
Hetero Atoms |
2 |
Heavy Atoms |
9 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
197.00 to 198.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.366 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.71 |
LogP |
0.945 |
iLOGP |
1.12 |
XLOGP3 |
0.52 |
WLOGP |
0.94 |
MLOGP |
0.31 |
ESOL Log S |
-0.88 |
ESOL Solubility (mg/ml) |
16.5 |
ESOL Solubility (mol/l) |
0.131 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-0.81 |
Ali Solubility (mg/ml) |
19.6 |
Ali Solubility (mol/l) |
0.16 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.56 |
Silicos-IT Solubility (mg/ml) |
3.43 |
Silicos-IT Solubility (mol/l) |
0.03 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.70 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.525 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.58 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |